Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

ASX finishes flat, Wesfarmers delivers again

ASX finishes flat, CSL (ASX:CSL), Wesfarmers (ASX:WES) delivers again, Fortescue (ASX:FMG) delivers record dividend The ASX200 (ASX:XJO) finished flat for the day, but with growing dispersion in underlying company performance. Treasury Wine (ASX:TWE) lead the way, jumping 17.5%, but it was healthcare company CSL (ASX:CSL) that contributed most with the consumer discretionary (+0.6%) and the healthcare (+2.0%) the few winners. Unemployment…
The Inside Investor | 18th Feb 2021 | More
An election win for investors, Nasdaq, S&P 500, and ASX 200 finish higher

Markets to open higher, ASX up 1.3% on the back of CSL (ASX: CSL), National Australia Bank (ASX: NAB) profit crushed, ‘Nirvana’ for sharemarkets. The ASX 200 (ASX: XJO) delivered another strong day as it became more clear that Joe Biden would be the next President of the United States. Despite the election still being…
Drew Meredith | 5th Nov 2020 | More
ASX market update; Victorian lockdowns extended

Victorian lockdowns extended, markets remain calm, Labor Day holiday in the US, ASX to open higher
Drew Meredith | 8th Sep 2020 | More
    • CSL: A true global leader

    In the latest of our never sell stocks, is one of Australia’s true global leaders, CSL, or Commonwealth Serum Laboratories. The company was founded in 1916 and was actually part of the Federal Government at the time. CSL is a biopharmaceutical company that researches, develops, manufactures and markets products to treat and prevent human medical…
    Drew Meredith | 7th Apr 2020 | More
    • 1 2